Effect of Tamm-Horsfall Protein on Calcium Oxalate Precipitation by Benković, Jasminka et al.
Benkovic et al: Effect of Tamm-Horsfall protein on calcium oxalate precipitation 705
Eur J Clin Chem Ciin Biochem
1995; 33:705-710
© 1995 Walter de Gruyter & Co.
Berlin · New York
Effect of Tamm-Horsfall Protein on Calcium Oxalate Precipitation
By Jasminka Benkovic1, Helga Furedi-Milhofer2, Vladimir Hlady2, Dubravka Cvoriscec1 and
Ana Stavljenic-Rukavina1
1 Klinicki zavod za laboratorijsku dijagnostiku, Klinicki bolnicki centar Zagreb, Zagreb, Hrvaiska
Clinical Institute of Laboratory Diagnosis, Zagreb University Clinical Hospital, Zagreb, Croatia
2 Institut Ruder Boskovic, Zagreb, Hrvatska
Ruder Boskovic Institute, Zagreb, Croatia
(Received May 11, 19947/January 20/August 3, 1995)
Summary: The effect of Tamm-Horsfall protein isolated from urine of healthy subjects on calcium oxalate precipita-
tion was studied in model systems of precipitation. The study was performed using following conditions: concentra-
tions of calcium chloride 10 mmol/1, sodium chloride 150 mmol/1, oxalic acid 300 μπιοΐ/ΐ; pH 6.0, and temperature
310 K. The concentration of Tamm-Horsfall protein varied between 1 —10mg/l. The kinetics of calcium oxalate
precipitation was observed by measuring the number and volume of particles in the suspension, and the precipitate
composition by an optic microscope. In all the studied systems, the precipitate morphology corresponded to pure
calcium oxalate monohydrate. Tamm-Horsfall protein was found to inhibit the growth of calcium oxalate monohy-
drate crystals and stimulate their aggregation in the given experimental conditions. Both effects were enhanced by
increase in the concentrations of Tamm-Horsfall protein and were most pronounced at the concentration of Tamm-
Horsfall protein of 10 mg/1.
Introduction
Tamm-Horsfall protein is a membrane glycoprotein orig-
inating from the kidney. It is formed in the epithelial
cells of the ascending limb of Henle's loop (1—4) and
in the proximal part of the distal tubule as a molecule
with a relative molecular mass of 80000. In urine of
healthy subjects, 90% of Tamm-Horsfall protein is found
in the form of aggregates with a relative molecular mass
of 7 Χ 106 (5) and to a minor extent (10%) in the form
of subunits (80000) and polymers (28'Χ 106) (6). The
role of Tamm-Horsfall protein in the formation of uri-
nary calculi has been known for quite some time, but
literature data on its action still vary considerably. Ac^
cording to some authors, Tamm-Horsfall protein is an
inhibitor of calcium crystal growth and aggregation
(7-9, 12, 17, 18), whereas others believe that it is actu-
ally a proinotor, of the above events (10, 11, 19). The
action of Tamm-Horsfall protein as an inhibitor or a
promoter of calcium oxalate crystal growth and aggre-
gation appears to depend on the degree of its aggrega-
tion (10), ionic strength of the medium and the glyco-
protein concentration. At low ionic strength, urine
Tamm-Horsfall protein acts as an inhibitor of calcium
oxalate crystallization (12). This inhibitory action is
also pronounced at very low concentrations of Tamm-
Horsfall protein (11). Tamm-Horsfall protein polymer-
ization in highly concentrated urine results in an oppo-
site action, i. e. in stimulation of calcium oxalate crys-
tal aggregation (10, 11). Such an effect of Tamm-
Horsfall protein is probably due to a decrease in urine
pH and increase in urine ionic strength (10). There-
fore, the aim of this study was to assess calcium
oxalate as the most common constituent of urinary
calculi, and to determine whether Tamm-Horsfall pro-
tein acts as an inhibitor or as a promotor of calcium
oxalate precipitation, and how Tamm-Horsfall protein
influences the processes of growth and aggregation of
calcium oxalate crystals.
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Materials and Methods
Tamm-Horsfall protein was isolated from urine of healthy adults,
males and females, by multiple precipitation with 0.58 mol/1 NaCl
(13, 14).
Pooled urine was diluted with equal amount of distilled water. So-
lution pH was adjusted to 5.0 using HC1 solution of 1 mol/1. Solid
NaCl was added to give a final concentration of 0.58 mol/1. The
urine was left at 4 °C for 48 h. The precipitate was collected by
centrifugation at 3000 min""1 for 20 min at 4 °C and washed with
ice-cold NaCl solution of 0.58 mol/1. The precipitate was dissolved
in 2 1 water. NaCl was then added to a final concentration of 0.58
mol/1 and the sample left overnight at 4 °C. The suspension was
centrifuged at 3000 min"1 for 20 min at 4 °C. The precipitate was
washed with ice-cold NaCl solution of 0.58 mol/1, and redissolved
in water. Following a further addition of NaCl, as described above,
the material was dissolved in the minimum amount of water and
dialysed against distilled water at 4 °C until free of chloride.
The purity of isolated Tamm-Horsfall protein was tested by immu-
noelectrophoresis with specific antiserum to Tamm-Horsfall protein
(IgG fraction, Institute of Immunology, Zagreb, Croatia) and com-
plete antihuman serum (Behring, Marburg, Germany). Complete
antihuman serum was used to determine whether isolated Tamm-
Horsfall protein is free of albumin and other serum proteins which
may be present in urine.
Protein concentration was determined by the method of Rieder (15)
and was found to be 2.5 g/1. The concentration was tested by meas-
uring the light absorption on a Hilger-H-700 instrument at a wave-
length of 277 nm. Protein concentration was calculated from
Ε = ε X c X d. εΓ£η = 10.8 at 277 nm (16). Solutions of Tamm-
Horsfall protein concentrations of 1, 2.5, 5, 7.5 and 10 mg/1 were
prepared by Tamm-Horsfall protein dilution with tridistilled water.
The solutions of NaCl of 150 mmol/1, CaCl2 of 20 mmol/1 and
oxalic acid of 600 μπιοΐ/ΐ were prepared from p,a. chemicals
(Kemika, Zagreb) and filtered through a 0.22 μηι Millipore filter.
Oxalic acid pH was adjusted to 6.0 using NaOH solutions of
1 mol/1 and 0.1 mol/1. All solutions were thermostasized at 310 K.
Precipitating systems were prepared by mixing equal volumes (100
ml) of NaCl-CaCl2 and NaCl-oxalic acid solutions, so that final
concentrations in the system were: 150 mmol/1 NaCl, 10 mmol/1
CaCl2 and 300 μιηοΐ/ΐ oxalic acid. Subsequently, an appropriate
amount of Tamm-Horsfall protein was added. Before the measure-
ment, the precipitating systems were mixed for l min at 340 min"1.
The kinetics of calcium oxalate precipitation was observed by the
analysis of changes in the values of total particle number (Ntot) and
total precipitate volume (Vtot) during 2 h, every 5 min, on a Coulter
Counter MO TA. Changes in the precipitate composition were ob-
served by an Orthoplan optical microscope (E. Leitz, Wetzlar). Nlot
is one of the output data of the Coulter particle counter, and the
values of Vtot were calculated from the output data for each meas-



















particle volume in the η canal
volume diameter of the η canal
volume percentage
total particle number
factor proportional to particle number in the η canal
particle number in the η canal
total particle volume in the η canal
total precipitate volume
The above mentioned formulas were used to calculate volume trac-
tions Vsingie (total particle volume with volume diameter of 1.62
μπι ^ d ̂  8.2 μηι) and Vaggr (total particle volume with volume
diameter of 8.2 μηι < d <52.0 μπι), as follows:
Vsingle = Σ Vn = Σ N„ v„
Vaggr = Σ Vn = Σ Nn vn
The Vsingie volume fraction corresponded to particles of small vol-
ume diameter, i. e. to individual crystals of calcium oxalate. The
Vaggr volume fraction included particles of large volume diameter
that correspond to aggregates of calcium oxalate crystals.
In addition, the crystal growth parameter, a, was defined as the
increase in the total volume of small particles (Vsingie) with time,
using the following formula:
_ Vsingie (t) - Vsingie (1-
where
VSingie (0 = total small particle volume at time t
Vsingie (1 nun) = total small particle volume at the beginning of
measurement (after l min)
t = time at which the slope of the Vsingie-time curve
reached its maximum
The crystal aggregation parameter, b, was defined as the change
in the proportion of aggregated particles (Vaggr) relative to total
precipitate volume (Vtot) from the beginning of measurement
(min 1) to min 50 of precipitation:
V.,» = vaggr(SO min) VaggrQ min)
Mot(SOmin) -v,tot(l min)
where
min) - volume of aggregated particles after l min
Vaggrcso min) = volume of aggregated particles after 50 min of pre-
cipitation
Vtot(i min) = total precipitate volume after l min
Vtot(5o min) = total precipitate volume after 50 min of precipita-
tion
Results
Testing of purity of isolated Tamm-Horsfall
protein
Immunoelectrophoresis with specific antiserum to
Tamm-Horsfall protein showed a single precipitate,
thereby we concluded that isolated protein was Tamm-
Horsfall protein. Immunoelectrophoresis with complete
antihuman serum showed no precipitate, i.e. isolated
Tamm-Horsfall protein was free of albumin and other
serum proteins.
Precipitation of calcium oxalate in a Tamm-
Horsfall protein-free system
Changes in the particle distribution according to their
number and volume are presented in figure 1> showing
that particles with volume diameter of < 8.2 μπι, i. e.
individual calcium oxalate crystals, predominated by
min 50 of precipitation, while the,proportion of aggre-
gated particles with volume diameters of > 8.2 μπι was
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negligible. Only later during precipitation did a shift in the
volume distribution toward large particles occur, indicat-
ing aggregation of calcium oxalate crystals. The curve de-
lineating the change in the distribution of particles ac-
cording to their number (fig. 1) shows the proportion of
particles with large volume diameter increased with time,
also pointing to particle aggregation. The presence of
pure calcium oxalate monohydrate in the precipitate was
demonstrated by optical microscopy.
The total number of particles Ntot increased abruptly dur-
ing the first five minutes of precipitation (systems with
oxalate concentrations of 300 μπιοΐ/l and 200 μιηοΐ/ΐ),
which was accompanied by a gradual increase in Vtot
(fig. 2), whereafter Ntot decreased and Vtot continued to
slowly rise for some time, which corresponded to the
phase of crystal growth. About min 30 of precipitation,
Vtot assumed constant values, whereas Ntot continued to
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Fig. 1 Change in distribution according to number (—O—) and
volume (histogram) of particles in a Tamm-Horsfall protein-free
system (c(NaCl) = 150 mmol/1, c(CaC!2) = 10 mmol/1, c(C2O4)
= 300 μχηοΐ/ΐ.
drate crystals. The system with the lowest oxalate con-
centration (150 μτηοΐ/ΐ) (fig. 2) revealed a considerably
slower increase in Ntot accompanied by a slight rise in
Vtot, clearly showing the rate of crystal growth and total
precipitate volume depends directly on the system oxa-
late concentration. Time-related changes in the Vsingle
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Fig. 3 Time-related change in total precipitate volume (Vtot) and
change in individual volume fractions (Vsingle and Vaggr) in a Tamm-
Horsfall protein-free system (c(NaCl) = 150 mmol/1, c(CaC!2
- 10 mmol/1, c(C2O4) = 300 μπιοΙ/1).
10 30 50
Time Γ min]
Fig. 2 Time-related change in total precipitate volume (Vtot) and
in total number of particles (Ntol) in a Tamm-Horsfall protein-free
system c(C2O4) =300 μιηοΐ/l (ο), 200 μηαοΐ/ΐ (Ο) and 150
μπιοΐ/l (Δ).
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calcium oxalate monohydrate crystals (Vsingle) predomi-
nated throughout the period of precipitation, whereas the
proportion of aggregates was low in comparison with
the total precipitate volume.
Calcium oxalate precipitation with
Tamm-Horsfall protein
During the precipitation, a large proportion in the total
precipitate volume referred to Tamm-Horsfall protein
molecules. Therefore, all results were corrected relative
to Tamm-Horsfall protein as follows: the volume mea-
sured before the beginning of precipitation, i. e. before
the addition of oxalate to the precipitating system, was
substracted from the precipitate volume for each time of
measurement.
A change in the particle distribution according to their
number and volume in a system with concentration of
Tamm-Horsfall protein of 10 mg/1 is shown in figure 4.
The volume distribution histogram reveals a consider-
able proportion of particles with a volume diameter of
> 8.2 μπι to have already been present at early precipi-
tation times (15 min). With time, a shift toward greater
crystal volumes was even more pronounced, pointing to
the occurrence of calcium oxalate monohydrate crystal
aggregation. This statement appears to be further sup-
ported by a presentation of time-related changes in the
Vsingie and Vaggr volume fractions (fig. 5), with calcium
oxalate monohydrate aggregates (Vaggr) making a large
proportion of the total precipitate volume.
Figure 6 shows time-related changes in the Vsingle and
Vaggr volume fractions in the precipitating systems with
lower Tamm-Horsfall protein concentrations (1, 2.5, 5
and 7.5 mg/1). At Tamm-Horsfall protein concentrations
greater than 2.5 mg/1, a significant proportion of par-
ticles with a volume diameter > 8.2 μιη (Vaggr) was ob-
served from the very beginning of precipitation. Optical
microscopy of the precipitate showed them to be
calcium oxalate monohydrate and Tamm-Horsfall pro-
tein aggregates. At the same time, a significant decrease
in the volume of small particles with a volume diameter
— 8.2 μπι (Vsingle) was observed. Also, the initial slopes
of the Vsingle-time curve declined with a rising Tamm-
Horsfall protein concentration, whereas the volume of
aggregated particles Vaggr(calcium oxalate monohydrate
and Tamm-Horsfall protein aggregates, optical micro-
scopy) increased with time and Tamm-Horsfall protein
concentration (fig. 7).
Discussion
Literature reports on the role of Tamm-Horsfall protein
in the formation of urinary calculi are quite contradic-
tory. The question is still open whether Tamm-Horsfall
protein acts as a promotor or as an inhibitor of calcium
oxalate precipitation, and how it acts upon particular
phases of the process of precipitation, i. e. nucleation,
growth and aggregation. According to some authors,
Tamm-Horsfall protein is an inhibitor of crystal growth
(7, 8, 12, 17) and aggregation (9, 18), while others have
shown promotion (10, 11, 19) or no effect (20, 21). This
contradiction is most probably due to the fact that vari-
ous studies were performed under different experimental
conditions (e.g., concentrations of electrolytes and
Tamm-Horsfall protein in aqueous solution or ultrafilt-
ered urine). Furthermore, Tamm-Horsfall protein is pre-
sent in the urine in the form of subunits and aggregates,
which may have different effects on crystal formation
(9, 10). This disagreement in the reports relating to
Tamm-Horsfall protein inspired us to embark upon a
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Fig. 4 o Change in distribution according to number (—o—) and
volume (histogram) of particles in a system with 10 mg/1 Tamm-
Horsfall protein (c(NaCl) = 150 mmol/1, c(CaC!2) = 10 mmol/1,
c(C2O4) = 300 μιηοΐ/ΐ).
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growth and aggregation of calcium oxalate crystals as
the most common constituent of urinary calculi. The
study was carried out using conditions in which pure
calcium oxalate monohydrate had been previously ob-
tained (22), i.e. c(NaCl) = 150 mmol/1, c(CaC!2) = 10
mmol/1, c(C2O4) = 300 μπιοΐ/l, pH 6.0 and temperature
310 K. The concentration of Tamm-Horsfall protein var-







Fig. 5 Time-related change in total precipitate volume (Vtot) and
change in individual volume fractions (Vsingle and Vaggr) in a sys-
tem with 10 mg/1 Hamm-Horsfall protein (c(NaCl) = 150 mmol/1,
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Fig. 6 Time-related change in Vsingle (a) and Vaggr (b) volume
fractions in systems with 1 mg/1 (·), 2.6 mg/1 (O), 5 mg/1 (Δ) and
7.5 mg/1 (D) Tamm-Horsfall protein.
protein concentrations higher than 10 mg/1 were avoided
because of additional self-aggregation of Tamm-Horsfall
protein, suspensions of which were not suitable for
Coulter Counter measurements. Comparison of the his-
tograms of the particle volume distribution in a system
with 10 mg/1 of Tamm-Horsfall protein (fig. 4) and in a
control system without Tamm-Horsfall protein (fig. 1)
reveals the particles of a volume diameter of < 8.2 μπι
(individual calcium oxalate monohydrate crystals) pre-
dominated in the control system throughout the period
of precipitation, whereas in the system with Tamm-
Horsfall protein large particles of d > 16.4 μπι predomi-
nated, suggesting the occurrence of calcium oxalate
monohydrate crystal aggregation in the presence of
Tamm-Horsfall protein. A diagram illustrating the time-
related change in the Vsingle and Vaggr volume fractions
(fig. 5) also differs considerably from that for the control
system (fig. 3). In the control system, the course of the
vsingie-time curve nearly overlaps with the course of the
Vtot-time curve. The proportion of the aggregates Vaggr
relative to the total precipitate volume was small, and
the volume of aggregated particles in min 50 of precipi-
tation was 1.1 Χ ΙΟ6 μπι3 cm"3. In contrast, in the sys-
tem with 10 mg/1 of Tamm-Horsfall protein, Vaggr ac-
counted for a large proportion in the total precipitate
volume, whereas the volume of aggregated particles in
min 50 of precipitation was 7.6 Χ ΙΟ6 μπι3 cm"3, which
confirms the hypothesis that Tamm-Horsfall protein
stimulates the aggregation of calcium oxalate monohy-
drate and is consistent with the results obtained by other
authors (10) who consider the polymer molecule of
Tamm-Horsfall protein to act as a promoter of calcium
oxalate crystal aggregation. Other authors, however, ad-
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Fig. 7 Dependence of the parameters of growth (a, curve 1) and
aggregation (b, curve 2) of calcium oxalate monohydrate crystal
on Tamm-Horsfall protein concentration.
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studies with Tamm-Horsfall protem subunits (9) or with
very low Tamm-Horsfall protein concentrations (11).
The time-related changes in the Vsingle and Vaggr volume
fractions (fig. 6) show that in the systems with i—7.5
mg/1 of Tamm-Horsfall protem, a gradual increase in the
concentration of Tamm-Horsfall protein resulted in a
significant decrease in the small particle volume (Vsingie)
early during the procedure of precipitation (by min 20),
indicating inhibition of crystal growth. The volume of
aggregated particles increased simultaneously, confirm-
ing the above conclusion that Tamm-Horsfall protein
acts as a promoter of the calcium oxalate monohydrate
crystal aggregation. A change in the calcium oxalate
monohydrate crystal growth (a) and aggregation (b)
parameters, depending on the concentration of Tamm-
Horsfall protein in the precipitating system (fig. 7),
clearly shows that in the given experimental conditions,
the presence of Tamm-Horsfall protein led to crystal
growth inhibition (curve 1), which was most pronounced
at a Tamm-Horsfall protein concentration of 10 mg/1. At
the same time, the parameter describing the intensity of
aggregation rose with the increase in the system concen-
tration of Tamm-Horsfall protein (cufve 2). Optical mi-
croscopy revealed that the aggregates consist of calcium
oxalate monohydrate and Tamm-Horsfall protein, and that
crystal growth is slowed down just by the process of
calcium oxalate monohydrate crystal aggregation to
Tamm-Horsfall protein molecules, supporting the conclu-
sion that, in the given experimental conditions, Tamm-
Horsfall protein acts as an inhibitor of calcium oxalate
monohydrate crystal growth and as a promotor of their ag-
gregation. The results obtained in this study may contrib-
ute to better understanding of the role of Tamm-Horsfall
protein in the formation of a solid phase in the urine,
which may be important in relation to urolithiasis.
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